newsfilter
← Latest News
GlobeNewswire·

Eliem Therapeutics Announces Plans to Explore Strategic Alternatives

SEATTLE and CAMBRIDGE, United Kingdom, July 20, 2023 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (NASDAQ:ELYM) today announced that it has completed a review of its business, including the status of its programs,